Many students appear to be completing assignments faster while learning less from them. This conclusion comes from one of the largest studies of how generative AI is changing student behavior and ...

Palantir CEO Alex Karp said that "something has gone completely wrong" in the AI market. "The enterprises are just tired of ...

Meta said on Wednesday its chief marketing officer Alex Schultz will become the company's first ​chief data officer, to ...

Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill patients have received an implant to treat ...

Detailed price information for Alx Oncology Holdings Inc (ALXO-Q) from The Globe and Mail including charting and trades.

Evorpacept's CD47 biomarker story shows early promise for ALX Oncology Holdings. Click here to read my most recent analysis ...

MORRISVILLE, N.C.--(BUSINESS WIRE)--Vast Therapeutics, a clinical-stage life science company developing nitric oxide-based medicines for serious lung diseases, today announced late-breaking Phase 1 ...

Vast Therapeutics, a clinical-stage life science company developing nitric oxide-based medicines for serious lung diseases, today announced late-breaking Phase 1 data for its inhaled drug candidate ...

Vast Therapeutics to Present Phase 1 Data on First-in-Class Nitric Oxide Therapy ALX1 at the American Thoracic Society 2026 International Conference Vast Therapeutics, a clinical-stage life science ...

Global infrastructure manager IFM Investors Pty is seeking to rally support from shareholders of Atlas Arteria Ltd. for its bid to acquire the toll road operator, a day after the Sydney-listed company ...